There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Senseonics Holdings (SENS – Research Report), Azitra Inc (AZTR – Research Report) and Dexcom (DXCM – Research Report) with bullish sentiments.
Senseonics Holdings (SENS)
In a report released today, Mathew Blackman from Stifel Nicolaus maintained a Buy rating on Senseonics Holdings, with a price target of $2.50. The company’s shares closed last Thursday at $0.70.
According to TipRanks.com, Blackman is a 4-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Senseonics Holdings with a $2.50 average price target.
See today’s best-performing stocks on TipRanks >>
Azitra Inc (AZTR)
Azitra Inc received a Buy rating and a $2.00 price target from Maxim Group analyst Jason McCarthy yesterday. The company’s shares closed last Thursday at $0.26, close to its 52-week low of $0.20.
According to TipRanks.com, McCarthy ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Azitra Inc has an analyst consensus of Moderate Buy, with a price target consensus of $2.00.
Dexcom (DXCM)
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom today and set a price target of $150.00. The company’s shares closed last Thursday at $115.07.
According to TipRanks.com, O’Brien is a 4-star analyst with an average return of
Dexcom has an analyst consensus of Strong Buy, with a price target consensus of $146.92.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SENS:
